Multiple ascending doses of Placebo

DRUG2 trials

Sponsors

Enterome, QurAlis Corporation

Conditions

Amyotrophic Lateral SclerosisHealthy Volunteers

Phase 1

First-in-Human Single and Multiple Dose of EB8018

CompletedNCT02998190

EnteromeHealthy Volunteers

Start: 2016-11-30End: 2017-08-31Updated: 2018-02-13

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Active, not recruitingNCT05633459

QurAlis CorporationAmyotrophic Lateral Sclerosis

Start: 2022-12-16End: 2027-11-30Updated: 2026-05-15